Creative Planning’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
PHS
CWG
RHJA
Creative Planning's AERI Position: Q4 2020 in Review
Creative Planning sold out of Aerie Pharmaceuticals (AERI) in Q4 2020, closing a stake of 22,000 shares — an estimated $259K sold.
Creative Planning first reported a position in AERI in Q1 2015 and held it in 20 quarters. The position peaked at $1.26M in Q1 2019. 150 funds tracked by Wall St. Rank hold AERI as of Q4 2020.
- Creative Planning reported no remaining Aerie Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Creative Planning sold 22,000 Aerie Pharmaceuticals shares in Q4 2020, an estimated $259K.
- Creative Planning first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 20 quarters.
- Creative Planning's Aerie Pharmaceuticals position peaked at $1.26M in Q1 2019.
- 150 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2020.
Based on Creative Planning's 13F filing for Q4 2020, filed 29 Jan 2021.